Integra Lifesciences Holdings Corp (STU:IL3)
€ 23.8 0.8 (3.48%) Market Cap: 1.83 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 71/100

Integra Lifesciences Holdings Corp at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2021 / 03:30PM GMT
Release Date Price: €60 (-1.64%)
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

So I think we are live waiting for some of the other video images to click in. I don't see everyone yet, but we'll get started. I think we'll -- folks will come on in another moment or so. So my name is Matt Miksic. I cover medical devices at Credit Suisse. I'm very pleased to have with us today Integra Life Sciences joining us again at our 30th Annual Healthcare Conference.

So we have Carrie Anderson, Executive Vice President and Chief Financial Officer, who we've definitely lost the video for, but I'm sure will come back on here in a moment. We have Mike Beaulieu, Director of Investor Relations. We also have Chris Ward, who will be joining and taking over the Investor Relations role at Integra.

So welcome, Chris.

Chris Ward

Thank you.

Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

And welcome, Carrie. If you can see us, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot